" Firenze restaura " : il dibattito sul restauro nella Firenze del Novecento attraverso i suoi protagonisti : dalla fondazione del Gabinetto dei Restauri all'alluvione

Résumé La ricerca del dibattito sul restauro nella Firenze del Novecento copre un arco temporale piuttosto lungo, che va dall'istituzione del Gabinetto dei restauri fiorentino, avvenuta tra il 1932 e il 1934 sino al 1966, anno della drammatica alluvione che travolse il patrimonio storico e artistico della città di Firenze. Sono più di trent'anni densi di storia, in cui grazie alla tradizionale vocazione artigiana messa in atto di volta in volta attraverso metodiche sperimentali, il Gabinetto dei restauri fiorentino, organizzato da Ugo Procacci affrontò dapprima l'emergenza bellica e, grazie alle esperienze maturate in quella circostanza, fronteggiò i danni provocati alle opere d'arte alluvionate. Lo scopo della ricerca è stato proprio quello di individuare gli aspetti ancora attuali del dibattito sul restauro e sulla conservazione. Filo conduttore è stato il dibattito sull'unificazione dei princìpi del restauro in Italia e quindi, dei suoi riflessi a Firenze. Nella prima parte della ricerca, trattando degli inizi dell'attività del Gabinetto dei restauri di Firenze era inevitabile studiare i riflessi che la creazione dell'Istituto Centrale del Restauro ha avuto sull'ambiente fiorentino. L'incombere della seconda guerra mondiale ebbe un peso determinante nell'accelerare i tempi di attuazione di un simile progetto: si temeva fortemente per le sorti del patrimonio artistico italiano e alle Soprintendenze sarebbe spettato il compito di mettere in salvo il maggior numero possibile di opere d'arte nei rifugi antiaerei e, successivamente, provvedere al restauro delle opere danneggiate: la questione dell'unificazione dei metodi da seguire nel campo del restauro e della conservazione delle opere d'arte era divenuta argomento di urgente attualità a guerra conclusa, soprattutto in vista del recupero delle opere danneggiate, Nella seconda parte del lavoro, trattando gli aspetti più attuali e quindi problematici della storia del restauro fiorentino, in particolare riferiti all'arco cronologico che va dalla metà degli anni Cinquanta sino alla fine degli anni Sessanta, è risultato di estremo interesse analizzare le cause e gli effetti della nota "stagione degli stacchi" e quindi l'avvio del dibattito sulla conservazione preventiva delle pitture murali esposte all'aperto. La questione relativa alla conservazione delle pitture murali esposte all'aperto, nei chiostri e nei tabernacoli, rappresentò il caso paradigmatico attorno al quale l'interesse e le soluzioni adottate per la salvaguardia dei cicli pittorici trovarono gli studiosi e i teorici del restauro italiani e stranieri per un'unica volta tutti concordi nell'avvalersi della prassi sistematica preventiva dello strappo delle pitture murali e del distacco delle sottostanti sinopie. Fu dunque questa l'unica occasione in cui si assistette ad una vera unificazione di intenti a livello nazionale.

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.

Via a transcription factor, Foxp3, immunoregulatory CD4(+)CD25(+) T cells (T reg cells) play an important role in suppressing the function of other T cells. Adoptively transferring high numbers of T reg cells can reduce the intensity of the immune response, thereby providing an attractive prospect for inducing tolerance. Extending our previous findings, we describe an in vivo approach for inducing rapid expansion of T reg cells by injecting mice with interleukin (IL)-2 mixed with a particular IL-2 monoclonal antibody (mAb). Injection of these IL-2-IL-2 mAb complexes for a short period of 3 d induces a marked (>10-fold) increase in T reg cell numbers in many organs, including the liver and gut as well as the spleen and lymph nodes, and a modest increase in the thymus. The expanded T reg cells survive for 1-2 wk and are highly activated and display superior suppressive function. Pretreating with the IL-2-IL-2 mAb complexes renders the mice resistant to induction of experimental autoimmune encephalomyelitis; combined with rapamycin, the complexes can also be used to treat ongoing disease. In addition, pretreating mice with the complexes induces tolerance to fully major histocompatibility complex-incompatible pancreatic islets in the absence of immunosuppression. Tolerance is robust and the majority of grafts are accepted indefinitely. The approach described for T reg cell expansion has clinical potential for treating autoimmune disease and promoting organ transplantation.

Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release.

Microglial cells react early to a neurotoxic insult. However, the bioactive factors and the cell-cell interactions leading to microglial activation and finally to a neuroprotective or neurodegenerative outcome remain to be elucidated. Therefore, we analyzed the microglial reaction induced by methylmercury (MeHgCl) using cell cultures of different complexity. Isolated microglia were found to be directly activated by MeHgCl (10(-10) to 10(-6) M), as indicated by process retraction, enhanced lectin staining, and cluster formation. An association of MeHgCl-induced microglial clusters with astrocytes and neurons was observed in three-dimensional cultures. Close proximity was found between the clusters of lectin-stained microglia and astrocytes immunostained for glial fibrillary acidic protein (GFAP), which may facilitate interactions between astrocytes and reactive microglia. In contrast, immunoreactivity for microtubule-associated protein (MAP-2), a neuronal marker, was absent in the vicinity of the microglial clusters. Interactions between astrocytes and microglia were studied in cocultures treated for 10 days with MeHgCl. Interleukin-6 release was increased at 10(-7) M of MeHgCl, whereas it was decreased when each of these two cell types was cultured separately. Moreover, addition of IL-6 to three-dimensional brain cell cultures treated with 3 x 10(-7) M of MeHgCl prevented the decrease in immunostaining of the neuronal markers MAP-2 and neurofilament-M. IL-6 administered to three-dimensional cultures in the absence of MeHgCl caused astrogliosis, as indicated by increased GFAP immunoreactivity. Altogether, these results show that microglial cells are directly activated by MeHgCl and that the interaction between activated microglia and astrocytes can increase local IL-6 release, which may cause astrocyte reactivity and neuroprotection.

Linee guida della consensus conference dell'ANGP per il monitoraggio plasmatico dei farmaci (TDM) in psichiatria. Aggiornamento 2011 =AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011

Therapeutic drug monitoring (TDM), i.e., the quantification of serum or plasma concentrations of medications for dose optimization, has proven a valuable tool for the patient-matched psychopharmacotherapy. Uncertain drug adherence, suboptimal tolerability, non-response at therapeutic doses, or pharmacokinetic drug-drug interactions are typical situations when measurement of medication concentrations is helpful. Patient populations that may predominantly benefit from TDM in psychiatry are children, pregnant women, elderly patients, individuals with intelligence disabilities, forensic patients, patients with known or suspected genetically determined pharmacokinetic abnormalities or individuals with pharmacokinetically relevant comorbidities. However, the potential benefits of TDM for optimization of pharmacotherapy can only be obtained if the method is adequately integrated into the clinical treatment process. To promote an appropriate use of TDM, the TDM expert group of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) issued guidelines for TDM in psychiatry in 2004. Since then, knowledge has advanced significantly, and new psychopharmacologic agents have been introduced that are also candidates for TDM. Therefore the TDM consensus guidelines were updated and extended to 128 neuropsychiatric drugs. 4 levels of recommendation for using TDM were defined ranging from "strongly recommended" to "potentially useful". Evidence-based "therapeutic reference ranges" and "dose related reference ranges" were elaborated after an extensive literature search and a structured internal review process. A "laboratory alert level" was introduced, i.e., a plasma level at or above which the laboratory should immediately inform the treating physician. Supportive information such as cytochrome P450 substrateand inhibitor properties of medications, normal ranges of ratios of concentrations of drug metabolite to parent drug and recommendations for the interpretative services are given. Recommendations when to combine TDM with pharmacogenetic tests are also provided. Following the guidelines will help to improve the outcomes of psychopharmacotherapy of many patients especially in case of pharmacokinetic problems. Thereby, one should never forget that TDM is an interdisciplinary task that sometimes requires the respectful discussion of apparently discrepant data so that, ultimately, the patient can profit from such a joint effort.

Est-il raisonnable d'être démocrate ?

Abstract : exploration de quelques apories de la démocratie ; et tout spécialement de l'idée de démocratie directe ; et défense de la thèse qu'il n'est pas raisonnable de penser qu'un régime politique autre puisse produire des résultats intrinsèquement supérieurs.

Prevenzione della malaria nei viaggiatori: quale antimalarico?: revisione Cochrane per il medico di famiglia.

Cet article présente les résultats de la revue systématique: Jacquerioz FA, Croft AM. Drugs for preventing malaria in travellers. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006491. PMID: 19821371